New Jersey seeks to ban PBMs, insurers from charging higher copays than actual price of drug

A proposed bill in New Jersey would ban insurers and pharmacy benefit managers from charging a higher copay than the cash price of a medication, according to New Jersey 101.5, a local radio station.

Advertisement

The bill would also prohibit “gag clauses” in contracts between PBMs or insurers and pharmacies. Gag orders prevent pharmacists from notifying patients they can obtain the drug for cheaper without using insurance.  

President Donald Trump signed a bill into law last year that banned gag orders. Implementation of the law is ongoing.

The New Jersey measure was unanimously approved by the Senate in late February. It now awaits Assembly approval.

More articles on pharmacy:
Harvard gets $100M infusion for drug research from hedge fund
Purdue Pharma CEO: Bankruptcy is ‘an option’ amid lawsuits
Intermountain CEO Dr. Marc Harrison: How Civica Rx will disrupt the drug industry

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.